Download Booklet - Diabetes in Asia Study Group
Download Booklet - Diabetes in Asia Study Group
Download Booklet - Diabetes in Asia Study Group
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Abstract Title<br />
Cost-effectiveness analysis of medical <strong>in</strong>tervention <strong>in</strong> patients with early detected of Diabetic<br />
nephropathy <strong>in</strong> a tertiary care hospital <strong>in</strong> bangladesh<br />
Authors : Samira Humaira Habib<br />
Co Authors : Salima Akter 2 , soma saha 1 , fahmida b<strong>in</strong>te Mesbah 1 , Mosaraf Hossa<strong>in</strong> 2 , Liaquat ali 1<br />
Conference Theme: Diabetic neuropathy <strong>in</strong> our region<br />
Abstract:<br />
background and aims: the economic burden result<strong>in</strong>g from Diabetic nephropathy (Dn) consumes<br />
a major portion of resources allocated for health-care services. Cost-effectiveness of various<br />
<strong>in</strong>terventions on Dn & its complications have relatively been well explored <strong>in</strong> developed countries,<br />
but these are almost absent <strong>in</strong> develop<strong>in</strong>g countries. the present study was undertaken to assess<br />
the cost-effectiveness of medical <strong>in</strong>tervention <strong>in</strong> patients with Dn.<br />
Materials and Methods: two hundred patients with Dn, with at least 1 yr of follow-up, were<br />
purposively selected from birDeM (tertiary diabetes care hospital) of bangladesh. of them 100<br />
were late <strong>in</strong> detection (serum Creat<strong>in</strong><strong>in</strong>e≥ 4.0 mmom/l, Late detected Dn or Late detected diabetic<br />
nephropathy) and 100 were detected early (serum Creat<strong>in</strong><strong>in</strong>e< 4.0 mmom/l, early detected Dn<br />
or early detected diabetic nephropathy). the degree & extent of complications like cardiopathy,<br />
peripheral neuropathy, ret<strong>in</strong>opathy & vasculopathy, treatment outcome, cl<strong>in</strong>ical effectiveness of<br />
<strong>in</strong>terventions and direct, <strong>in</strong>direct & <strong>in</strong>cremental cost of complications were calculated. Comparison<br />
was made between the groups. Cost <strong>in</strong>cluded drugs, hospitalizations, diagnostics & visits.<br />
results: a total of 200 patients were considered for an average of 365 days, amount<strong>in</strong>g to 651 personyears<br />
of observation <strong>in</strong> total. the mean±sD fast<strong>in</strong>g serum glucose of the groups was 9.36±0.40<br />
mmol/l & 4.78±0.38 mmol/l, total cholesterol was 206.50±42.60 & 104.20±35.50 mg/dl, hba 1c was<br />
9.80±0.50% & 5.70±0.38%, tG was 163.76±99.46 & 155.67±94.84 mg/dl and serum creat<strong>in</strong><strong>in</strong>e was<br />
0.89±0.03 & 4.90±1.17 mmol/l <strong>in</strong> Late detected diabetic nephropathy & early detected diabetic<br />
nephropathy respectively. about 19% patients <strong>in</strong> Late detected diabetic nephropathy & 36% <strong>in</strong><br />
early detected diabetic nephropathy were free of diabetic complications other than Dn. <strong>in</strong> Late<br />
detected diabetic nephropathy, 32% had one complication, 29% had two & 20% had more than<br />
two complications. on the other hand, <strong>in</strong> early detected diabetic nephropathy the correspond<strong>in</strong>g<br />
values were 48%, 10% & 6% respectively. the most frequent complication was cardiopathy, which<br />
affected 33% patients <strong>in</strong> Late detected diabetic nephropathy & 27% <strong>in</strong> early detected diabetic<br />
46